Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 241 citing Price: Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective. (0.09 sec) 

Long-term, low-intensity warfarin therapy for the prevention of recurrent venous …

- vcu.edu [PDF] 
PM Ridker, SZ Goldhaber, E Danielson, Y … - The New England journal of medicine, 2003 - nejm.highwire.org
Results The trial was terminated early after 508 patients had undergone
randomization and had been followed for up to 4.3 years (mean, 2.1). Of 253
patients assigned to placebo, 37 had recurrent venous thromboembolism (7.2 ...
Cited by 513 - Related articles - BL Direct - All 15 versions

Vascular-bed-specific hemostasis and hypercoagulable states

- kfshrc.edu.sa [PDF] 
RD Rosenberg, WC Aird - New England Journal of Medicine, 1999 - content.nejm.org
Hemostasis is a physiologic mechanism that maintains blood in a fluid state
within the circulation. The coagulation of blood is mediated by cellular
components and soluble plasma proteins. In response to vascular injury, ...
Cited by 435 - Related articles - BL Direct - All 10 versions

Postmenopausal hormone replacement therapy and the primary prevention of …


LL Humphrey, BKS Chan, HC Sox - Annals of internal medicine, 2002 - Am Coll Physicians
Data Sources: MEDLINE and Cochrane databases were searched for all primary
prevention studies reporting CVD or CAD incidence, mortality, or both in
association with HRT; reference lists, letters, editorials, and reviews ...
Cited by 237 - Related articles - BL Direct - All 4 versions

G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous …

- ahajournals.org
PM Ridker, CH Hennekens, JP Miletich - Circulation, 1999 - Am Heart Assoc
Methods and Results—In a prospective cohort of 14 916 men, we determined the
prevalence of the G20210A prothrombin gene variant in 833 men who subsequently
developed myocardial infarction, stroke, or venous thrombosis (cases) and ...
Cited by 208 - Related articles - BL Direct - All 5 versions

Pulmonary Embolism: What Have We Learned Since Virchow?*


JE Dalen - Chest, 2002 - chestjournal.chestpubs.org
Given the high mortality rate (30 to 35%) of patients with acute pulmonary
embolism (PE) if it is untreated (Table 1 ), therapy should be initiated when PE
is first seriously considered. The diagnosis can be confirmed by a positive ...
Cited by 189 - Related articles - BL Direct - All 12 versions

Venous thromboembolism


TM HYERS - American journal of respiratory and critical care …, 1999 - 171.66.122.149
Venous thromboembolism (VTE) is a complex vascular disease with a multifactorial
pathogenesis that results in two major clinical manifestations. The first and
more common manifestation is deep venous thrombosis (DVT), which usually ...
Cited by 174 - Related articles - BL Direct - All 6 versions

Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on …


RA Lobo, T Bush, BR Carr, JH Pickar - Fertility and sterility, 2001 - Elsevier
Objective: To determine the effects of lower doses of conjugated equine
estrogens (CEE) alone or CEE and medroxyprogesterone acetate (MPA) on
lipoproteins, carbohydrate metabolism, and coagulation/fibrinolytic factors.
Cited by 157 - Related articles - BL Direct - All 12 versions

Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among …

- annals.org
RH White, H Zhou, PS Romano - Annals of internal medicine, 1998 - Am Coll Physicians
Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Background: Few studies have compared the incidence of deep venous ...
Cited by 133 - Related articles - BL Direct - All 3 versions

Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events …

- ahajournals.org
DM Herrington, E Vittinghoff, TD Howard, DA … - Arteriosclerosis, thrombosis, and vascular biology, 2002 - Am Heart Assoc
Abstract— Oral contraceptive use in women with factor V Leiden is associated
with increased rates of venous thromboembolic events (VTEs). However, the
effects of hormone replacement therapy (HRT) in postmenopausal women with ...
Cited by 123 - Related articles - BL Direct - All 9 versions

Preeclampsia and genetic risk factors for thrombosis: a case-control study

- leidenuniv.nl [PDF] 
CJM De Groot, KWM Bloemenkamp, EJ Duvekot … - American journal of obstetrics and gynecology, 1999 - Elsevier
Recently, abnormal placentation has been associated with an increased tendency
toward thrombosis. [5] and [6] The tendency toward thrombosis in women with
preeclampsia might be the result of the combination of an acquired risk ...
Cited by 100 - Related articles - BL Direct - All 11 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google